Immunohistochemical Characterization of Bcl-2 in Oral Potentially Malignant Disorders
- 17 May 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 29 (9) , 706-712
Abstract
Bcl-2 is a group of apoptotic proteins that play a key role in cellular homeostasis. Overexpression of Bcl-2 has been associated with the poor prognosis of oral squamous cell carcinoma (OSCC). The aim of this study is to analyze the immunohistochemical expression of Bcl-2 in healthy oral mucosa, different oral potentially malignant disorders and OSCC, and to determine its diagnostic value. A retrospective observational study was carried out in the Oral Medicine Unit of the University of Santiago de Compostela. All the clinicopathologic data were collected and paraffin-embedded blocks were available to perform the immunohistochemistry study with Bcl-2. We studied 18 fibromas, 15 OSCC, 29 oral leukoplakia lesions (OL), 59 oral lichen planus (OLP) cases, and 16 healthy controls. OL with epithelial dysplasia (31.2%) showed the highest expression of Bcl-2 and OLP (1.9%) showed the lowest expression of Bcl-2 (P=0.025). Receiver operating characteristics curves showed that the detection of Bcl-2 enables discrimination between OL and OLPs (sensitivity: 58.6%, specificity of 99.32%). Bcl-2 negative expression in the OLP diagnosis obtained an odds ratio of 13.750 (95% confidence interval: 3.354-56.369; PP=0.001). Bcl-2 could be used as a diagnostic biomarker to study their malignant transformation.Keywords
This publication has 21 references indexed in Scilit:
- Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinomaInternational Journal of Oral and Maxillofacial Surgery, 2011
- Increased caspase-3 and altered expression of apoptosis-associated proteins, Bcl-2 and Bax in lichen planusClinical and Experimental Dermatology, 2009
- Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinomaOral Oncology, 2009
- Prognostic significance of Bcl‐2 and Bax protein expression in the patients with oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2009
- Bcl-2–family proteins and hematologic malignancies: history and future prospectsBlood, 2008
- The p53–Bcl-2 connectionCell Death & Differentiation, 2006
- Expression of Bcl‐2 but not Bax has a prognostic significance in tongue carcinomaJournal of Oral Pathology & Medicine, 2006
- The Hallmarks of CancerCell, 2000
- Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesionsCancer Letters, 1996
- Involvement of the bcl -2 Gene in Human Follicular LymphomaScience, 1985